Shuhei Kawasaki

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Daisuke Douchi · 2 shared papers, 2017–2021 · strength 0.17
   • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗
   • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
2. Michiaki Unno · 2 shared papers, 2017–2021 · strength 0.17
   • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗
   • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
3. Fuyuhiko Motoi · 2 shared papers, 2017–2021 · strength 0.17
   • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗
   • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
4. Kei Nakagawa · 1 shared paper, 2021 · strength 0.11
   • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗
5. Masamichi Mizuma · 1 shared paper, 2021 · strength 0.11
   • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗
6. Kyohei Ariake · 1 shared paper, 2021 · strength 0.11
   • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗
7. Takanori Morikawa · 1 shared paper, 2021 · strength 0.11
   • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗
8. Masaki Sato · 1 shared paper, 2021 · strength 0.11
   • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗
9. Kei Kawaguchi · 1 shared paper, 2017 · strength 0.06
   • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
10. Yu Katayose · 1 shared paper, 2017 · strength 0.06
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
11. Shinichi Egawa · 1 shared paper, 2017 · strength 0.06
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
12. Koetsu Inoue · 1 shared paper, 2017 · strength 0.06
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
13. Tetsuya Terasaki · 1 shared paper, 2017 · strength 0.06
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.